Evaluation of the CBSM Program Online and in Person to Reduce Caregiver Burnout (Caregiver-CBSM)

April 8, 2025 updated by: University Hospital, Grenoble

Promotion of Mental Health and Prevention of Burnout Among Caregivers at CHU Grenoble Alpes (CHUGA) and CH Métropole Savoie (CHMS) Through a Stress Management Intervention Based on Cognitive Behavioral Therapies.

Professional burnout is a common syndrome among healthcare workers, impacting both their well-being and the quality of care provided . It is characterized by emotional exhaustion, depersonalization, and a reduced sense of personal accomplishment.

This multicenter study evaluates the effectiveness of the Cognitive Behavioral Stress Management (CBSM) program in preventing burnout. This intervention, based on cognitive-behavioral techniques, integrates stress management tools and relaxation exercises over eight 2-hour sessions. The study aims to recruit 200 healthcare workers, divided into three groups: in-person intervention, hybrid format (videos + videoconferences), and delayed intervention (in-person/hybrid), across two hospital centers (CHUGA and CHMS). Data will be collected at three time points (M0, M3, M6), with emotional exhaustion (MBI) as the primary outcome, supplemented by measures of individual, relational, and organizational factors.

By comparing different intervention modalities (in-person vs. hybrid, immediate vs. delayed), this research will provide practical recommendations to enhance burnout prevention strategies in the hospital setting.

Study Overview

Detailed Description

This project aims to evaluate the effectiveness of the Cognitive Behavioral Stress Management (CBSM) program in preventing burnout, a widespread issue among healthcare professionals. Burnout, particularly characterized by emotional exhaustion, depersonalization, and reduced personal accomplishment, has severe consequences on caregivers' mental and physical health as well as the quality of care provided. In this context, the CBSM program, originally developed for patients, has been modified and adapted specifically to meet the needs of healthcare professionals. It is a multidimensional program combining various techniques such as relaxation, cognitive and emotional management, coping strategies and enhancement of social support and assertiveness. Numerous previous studies have demonstrated the effectiveness of CBSM in reducing stress, anxiety, and depressive symptoms, as well as in improving the long-term quality of life of participants.

The current project plans to form 12 groups of 10 people, split between the two institutions, with two intervention modalities: in-person group sessions and a hybrid format. The latter includes podcasts and three virtual sessions (at the beginning, middle, and end of the program). Participants, whether medical or non-medical staff, will complete standardized questionnaires before the intervention begins (M0), at the end of the intervention (M3), and six months later (M6). Data collection will take place from May 2025 to December 2026, with the last inclusion scheduled for October 2026.

All data will be collected via questionnaires:

  • The Maslach Burnout Inventory (MBI), which will assess the three dimensions of burnout: emotional exhaustion, depersonalization, and personal accomplishment.
  • The Perceived Stress Scale (PSS-14), which will measure the participants' perceived stress levels.
  • The Hospital Anxiety and Depression Scale (HADS), which will evaluate symptoms of anxiety and depression among participants.
  • The Professional Quality of Life Scale (ProQOL), which will assess participants' professional quality of life.
  • The Ruminative Response Scale (RRS), which will evaluate participants' tendencies toward rumination.
  • The Coping Flexibility Scale-Revised (CFS-R), which will measure individuals' ability to evaluate the effectiveness of their coping strategies and to replace them when they are not effective.
  • A questionnaire on program satisfaction and adherence.
  • Sociodemographic data (age, gender, years of experience in the profession) to identify variations in the effectiveness of the intervention based on caregivers' profiles.
  • Questions regarding perceptions of working conditions.
  • One item measuring sleep quality.
  • Two items measuring social support at work and outside of work.

The expected outcomes of this study aim to enrich the scientific literature on burnout prevention and stress management in healthcare professionals, providing recommendations on best practices to be disseminated across healthcare institutions. The results will also be used to develop continuing education programs designed to strengthen healthcare professionals psychosocial skills.

Study Type

Interventional

Enrollment (Estimated)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Chambéry, France, 73000
        • Centre Hospitalier Métropole Savoie (CHMS)
      • Grenoble, France, 38000
        • Centre hospitalier Grenoble Alpes (CHUGA)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria :

  • Be a healthcare professional.
  • Be a volunteer.
  • Work at CHUGA or CHMS.
  • Be available to attend program sessions (in-person or hybrid).

Exclusion criteria:

  • Protected persons (articles L1121-5 to L1121-8 of the Public Health Code), except for pregnant women for whom a benefit is expected in relation to a foreseeable minor risk for the pregnant woman or the unborn child.
  • Students in health-related fields.
  • Individuals with difficulties in understanding the French language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CBSM Intervention in In-Person Group Format
  • 8 CBSM sessions
  • The sessions will take place in a group setting, face-to-face, within the institution.
The CBSM sessions will be delivered to participants in groups of ten, totaling eight sessions, each focused on a specific theme related to stress management. All participants will attend the complete sessions in person.
Experimental: Hybrid CBSM Intervention
  • 8 CBSM sessions
  • This format combines podcasts to listen to, along with three online sessions via video conferencing (at the beginning, middle, and end of the program).
The CBSM (hybrid) sessions will be offered to participants online, including a total of eight video modules, each dedicated to a specific theme related to stress management. Participants will also have access to three interactive virtual sessions, summary sheets in PDF format, and audio recordings for relaxation.
No Intervention: Delayed CBSM Intervention
Participants will participate in the program at a delayed time to form a control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of the Emotional Exhaustion Dimension of the Maslach Burnout Inventory (MBI)
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
The scores for the emotional exhaustion dimension of the Maslach Burnout Inventory (MBI) range from 0 to 54. A higher score indicates a higher level of emotional exhaustion.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scores of Depersonalization and Personal Accomplishment from the Maslach Burnout Inventory (MBI).
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
The scores for the depersonalization dimension of the Maslach Burnout Inventory (MBI) range from 0 to 30. A higher score indicates a higher level of depersonalization. For the personal accomplishment dimension, scores range from 0 to 48, where a lower score signifies reduced personal accomplishment.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Perceived stress assessed by the Perceived Stress Scale (PSS-14)
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Anxiety and depression assessed by the Hospital Anxiety and Depression Scale (HADS).
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
The Hospital Anxiety and Depression Scale (HADS) assesses two dimensions: anxiety (HADS-A) and depression (HADS-D), each with a minimum score of 0 and a maximum score of 21. Higher score indicates significant clinical symptoms of anxiety or depression.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Quality of life at work assessed by the Professional Quality of Life (ProQOL) Scale.
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Individual scores on the ProQOL can range from 0 to 30. Higher score indicates the following: for Compassion Satisfaction (CS), it reflects a strong joy in helping others; for Burnout (BO), it signifies a high level of professional exhaustion; and for Secondary Traumatic Stress (STS), it denotes a significant level of secondary traumatic stress related to others' experiences.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
working conditions questionnaire
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Individual scores on the working conditions questionnaire can range from 0 to 90. Higher score indicates good working conditions.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
socio-demographic data questionnaire
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Age, gender, type of hospital service...
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Rumination assessed by the Rumination Response Scale. (RRS)
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
Individual scores on the RSS can range from 5 to 20 for each subscale. (Brooding and reflexion) Higher score reflects a high tendency to ruminate.
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
A questionnaire on program satisfaction and adherence.
Time Frame: Month 3; Month 6 for the immediate intervention group and Month 6; Month 9 for the delayed intervention group
It will assess participants' level of satisfaction with the program (e.g., content relevance, usefulness, delivery format) and their engagement (e.g., attendance, completion of exercises). This questionnaire will help identify areas for improvement and better understand participants' experience with the intervention.
Month 3; Month 6 for the immediate intervention group and Month 6; Month 9 for the delayed intervention group
Coping flexibility
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group

12-item self-report measure assessing individuals' ability to evaluate and adjust their coping strategies based on their effectiveness. It reflects the dynamic process of stress management, where a person may modify or abandon a strategy if it proves ineffective or harmful. Participants rate each item on a 4-point scale (0 = not applicable to 3 = very applicable).

The scale includes three subdimensions:

Abandonment - ability to discontinue ineffective coping strategies Re-coping - ability to generate and apply alternative strategies Meta-coping - awareness and evaluation of coping effectiveness

A higher total score indicates greater coping flexibility.

Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
1 item measuring sleep quality.
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
"Over the past month, how would you rate the overall quality of your sleep?" 0 = Very poor to 10 = Very good
Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group
2 items measuring social support:
Time Frame: Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group

"Overall, to what extent do you feel supported outside of work (family, friends, etc.)?"( 0 = Very little support to 10 = Very well supported)

"Overall, to what extent do you feel supported at work?" ( 0 = Very little support to 10 = Very well supported)

Month 0; Month 3; Month 6 for the immediate intervention group and Month 0; Month 3; Month 6; Month 9 for the delayed intervention group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Aurélie Gauchet, Professor, Université Savoie Mont Blanc
  • Study Director: Nour Chiboub, doctoral student, Université Savoie Mont Blanc
  • Study Director: Anne-Sophie Wasmer, Doctor, Centre Hospitalier Métropole Savoie (Chambéry)
  • Study Director: Véronique Bollongeat, Doctor, Centre Hospitalier Universitaire Grenoble Alpes
  • Study Chair: Jean-Luc Bosson, Professor, Centre Hospitalier Universitaire Grenoble Alpes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

September 26, 2024

First Submitted That Met QC Criteria

October 1, 2024

First Posted (Actual)

October 3, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2025

Last Update Submitted That Met QC Criteria

April 8, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 38RC24.0301
  • 2024-A01832-45 (Other Identifier: ID RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout, Caregiver

Clinical Trials on Cognitive Behavioral Stress management in in person group Format

Subscribe